Glycerol phenylbutyrate
![]() | |
| Clinical data | |
|---|---|
| Trade names | Ravicti |
| AHFS/Drugs.com | ravicti |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | A16AX09 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | 611168-24-2 |
| PubChem (CID) | 10482134 |
| DrugBank | DB08909 |
| ChemSpider | 8657541 |
| ChEMBL | CHEMBL2105745 |
| ECHA InfoCard | 100.228.552 |
| Chemical and physical data | |
| Formula | C33H38O6 |
| Molar mass | 530.651 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.[1]
References
This article is issued from Wikipedia - version of the 9/4/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
